PHLEXGLOBAL LIMITED
Get an alert when PHLEXGLOBAL LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-06-30 (in 1mo)
Last filed for 2024-09-30
Confirmation statement due
2026-04-27
Overdue
Watchouts
Cash
£2M
Latest balance sheet
Net assets
£19M
Equity attributable
Employees
146
Average over period
Profit before tax
-£23M
Period ending 2024-09-30
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Confirmation statement overdue
Due 2026-04-27.
Name history
Renamed 4 times since incorporation — the current trading name was adopted 2026-01-09
- PHLEXGLOBAL LIMITED 2026-01-09 → present
- CENCORA DIGITAL SOLUTIONS UK LIMITED 2025-05-29 → 2026-01-09
- PHLEXGLOBAL LIMITED 2002-04-15 → 2025-05-29
- PHLEX RECRUITMENT AGENCY LIMITED 1998-04-28 → 2002-04-15
- PHELX RECRUITMENT AGENCY LIMITED 1998-04-14 → 1998-04-28
Net assets
2-year trend · vs Industrials median
Accounts
2-year trend · latest reflected 2024-09-30
| Metric | Trend | 2023-09-30 | 2024-09-30 |
|---|---|---|---|
| Turnover | £5,217,000 | £7,670,000 | |
| Operating profit | -£1,764,000 | -£24,024,000 | |
| Profit before tax | £19,357,000 | -£23,169,000 | |
| Net profit | £19,951,000 | -£22,769,000 | |
| Cash | £1,874,000 | £2,139,000 | |
| Total assets less current liabilities | £54,739,000 | £20,215,000 | |
| Net assets | £54,118,000 | £19,481,000 | |
| Equity | £54,118,000 | £19,481,000 | |
| Average employees | 127 | 146 | |
| Wages | £4,932,000 | £7,468,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-09-30 | 2024-09-30 |
|---|---|---|---|
| Operating margin | -33.8% | -313.2% | |
| Net margin | 382.4% | -296.9% | |
| Return on capital employed | -3.2% | -118.8% | |
| Gearing (liabilities / total assets) | 47.5% | 51.2% | |
| Current ratio | 1.42x | 0.91x | |
| Interest cover | -4.19x | -208.90x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Rödl & Partner Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the Directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for a year of at least twelve months from when the financial statements are authorised for issue.”
Group structure
- PHLEXGLOBAL LIMITED · parent
- Phlexglobal Poland SP Zoo 100%
Significant events
- “On 30 September 2023 the company was part of the group of companies within the Cencora group, which was composed of Pharmalex UK Bidco Limited and its subsidiaries (the Group). In October 2023 an entity rationalisation project started whereby, on 31 October 2023, the company's immediate parent within the Pharmalex UK Bidco group, Emerald Bidco Limited, sold its investment in the company to an affiliate in the Cencora group, Pharmalex UK Holding Limited. This transaction was a transfer of the trading entities in the group to a new parent, but it had no impact on the continuing operations of the company. In August 2024, another entity rationalisation project started whereby: On 31 August 2024, an affiliate, Net Solutions Europe Ltd, entered into an agreement to transfer its trade and net assets to the company, excluding the intercompany trading balance (NSE Loan Note) owed by the company to Net Solutions Europe Ltd. An affiliate in the Cencora group, Pharmalex UK Holding Limited, contributed to the settlement of the NSE Loan Note, in return for the company issuing equity.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 20 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| GAUGLITZ, Christopher | Director | 2023-03-31 | Oct 1978 | German |
| SAMRA, Harjit Singh | Director | 2024-10-31 | Jan 1971 | British |
| TEISSEDRE, Olivier Pierre Louis | Director | 2026-02-11 | Feb 1977 | British |
Show 20 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| DONOGHUE, Stella Mary | Secretary | 2008-04-18 | 2016-12-09 |
| MURGATROYD, Nicola | Secretary | 1998-04-14 | 2008-04-18 |
| CO FORM (SECRETARIES) LIMITED | Corporate Nominee Secretary | 1998-04-14 | 1998-04-14 |
| CLARKE, Ray | Director | 2008-04-18 | 2011-03-25 |
| COUSTON, Laurent Maurice Robert | Director | 2023-03-31 | 2024-10-31 |
| DOBMEYER, Thomas Stefan | Director | 2022-01-24 | 2023-03-31 |
| DONOGHUE, Stella Mary | Director | 2008-04-18 | 2016-12-09 |
| GOODWIN, Nicola, Doctor | Director | 1999-05-15 | 2004-08-30 |
| JAMES, Kevin | Director | 2011-03-25 | 2011-07-29 |
| JETHWA, Dipesh | Director | 2023-02-22 | 2025-05-21 |
| JOHNSON, Anthony David | Director | 2020-01-07 | 2022-07-15 |
| MCNANEY, Peter James | Director | 2013-01-18 | 2017-11-24 |
| MCNEILL, John | Director | 2019-03-28 | 2023-02-22 |
| MURGATROYD, Nicola | Director | 1998-04-14 | 2011-03-25 |
| MURGATROYD, Nigel | Director | 1998-04-14 | 2011-03-25 |
| RIEGEL, Richard James | Director | 2015-04-13 | 2019-03-28 |
| ROY, Karen Jane | Director | 2008-04-18 | 2022-02-11 |
| SWIATEK, Stephen | Director | 2008-04-18 | 2011-03-25 |
| VENESS, Jacqueline Susan | Director | 2016-10-21 | 2019-12-04 |
| CO FORM (NOMINEES) LIMITED | Corporate Nominee Director | 1998-04-14 | 1998-04-14 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Pharmalex Uk Bidco Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2023-10-31 | Ceased 2023-10-31 |
| Pharmalex Uk Holding Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2023-10-31 | Active |
| Emerald Bidco Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-15 | Ceased 2023-10-31 |
Filing timeline
Last 20 of 178 total filings
Material constitutional events — rename, articles re-file, resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-02-11 | AP01 | officers | Appoint person director company with name date | |
| 2026-01-30 | AD01 | address | Change registered office address company with date old address new address | |
| 2026-01-09 | CERTNM | change-of-name | Certificate change of name company | |
| 2025-06-03 | AD01 | address | Change registered office address company with date old address new address | |
| 2025-05-29 | CERTNM | change-of-name | Certificate change of name company | |
| 2025-05-27 | TM01 | officers | Termination director company with name termination date | |
| 2025-05-21 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-03-20 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2025-03-20 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2025-03-19 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2025-03-19 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2025-01-24 | AA | accounts | Accounts with accounts type full | |
| 2024-12-16 | RP04SH01 | capital | Second filing capital allotment shares | |
| 2024-11-18 | AP01 | officers | Appoint person director company with name date | |
| 2024-11-15 | TM01 | officers | Termination director company with name termination date | |
| 2024-09-26 | SH01 | capital | Capital allotment shares | |
| 2024-04-17 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-03-04 | AD01 | address | Change registered office address company with date old address new address | |
| 2024-03-04 | AD01 | address | Change registered office address company with date old address new address | |
| 2024-02-20 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 7
- Capital events
- 2
- Officers appointed
- 1
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-09-30 vs 2023-09-30